Frazier Life Sciences Management, L.P. 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
FL Frazier Life Sciences Management, L.P. | Institutional Filer | ▲ 4.39% | $3.89B | 38 |
Current Portfolio Holdings
Showing all 38 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | MIRM | Mirum Pharmaceuticals, Inc. | Healthcare | 7.7M | $709.4M | 18.25% |
| 2 | NAMS | NewAmsterdam Pharma Company N.V. | Healthcare | 16.9M | $542.4M | 13.96% |
| 3 | ERAS | Erasca, Inc. | Healthcare | 24.7M | $399.2M | 10.27% |
| 4 | BBIO | BridgeBio Pharma, Inc. | Healthcare | 3.4M | $256.1M | 6.59% |
| 5 | ARQT | Arcutis Biotherapeutics, Inc. | Healthcare | 9.9M | $232.6M | 5.99% |
| 6 | MBX | MBX Biosciences, Inc. Common Stock | Healthcare | 6.7M | $198.6M | 5.11% |
| 7 | PHAT | Phathom Pharmaceuticals, Inc. | Healthcare | 12.5M | $138.5M | 3.56% |
| 8 | MAZE | Maze Therapeutics, Inc. | Healthcare | 4.6M | $136.3M | 3.51% |
| 9 | KRYS | Krystal Biotech, Inc. | Healthcare | 481K | $124.3M | 3.20% |
| 10 | TRVI | Trevi Therapeutics, Inc. | Healthcare | 9.9M | $118.6M | 3.05% |
| 11 | PVLA | Palvella Therapeutics, Inc. | Healthcare | 882K | $110.0M | 2.83% |
| 12 | KALV | KalVista Pharmaceuticals, Inc. | Healthcare | 5.0M | $99.9M | 2.57% |
| 13 | IRON | Disc Medicine, Inc. | Healthcare | 1.4M | $86.6M | 2.23% |
| 14 | CYTK | Cytokinetics, Incorporated | Healthcare | 1.2M | $76.4M | 1.97% |
| 15 | RVMD | Revolution Medicines, Inc. | Healthcare | 676K | $65.7M | 1.69% |
Showing 1 to 15 of 38 holdings